Me2Myself

Me2Myself M2M is a journey to move inwards from the external world to our inner world! Register for our 1-2-1 Reducing Chronic Pain and Inflammation!

Lifestyle Therapies in uncertain Times. Classes: Online classes for yoga and meditation. Consultations: Consult our life coaches for better health and wellness. Programs: Special programs for self-experience and self-exploration.

A guide to immunotherapy for COVID-19 https://www.nature.com/articles/s41591-021-01643-9
01/22/2022

A guide to immunotherapy for COVID-19 https://www.nature.com/articles/s41591-021-01643-9

This Review aims to support clinical decision-making by providing an overview of the evidence for immunotherapy strategies in patients with COVID-19.

01/22/2022

Neutralizing antibodies against the SARS-CoV-2 Omicron variant following homologous and heterologous CoronaVac or BNT162b2 vaccination https://www.nature.com/articles/s41591-022-01704-7

Serum neutralizing antibody titers against the SARS-CoV-2 Omicron variant markedly increase following a third dose of BNT162b2 in individuals who had previously received either two doses of the BNT162b2 vaccine or two doses of the CoronaVac vaccine.

Post-acute neurological consequences of COVID-19: an unequal burden https://www.nature.com/articles/s41591-021-01647-5  ...
01/18/2022

Post-acute neurological consequences of COVID-19: an unequal burden https://www.nature.com/articles/s41591-021-01647-5

COVID-19 and its neurological consequences particularly burden marginalized communities, and so can only be effectively treated by advancing health equity.

01/08/2022

The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension https://www.nature.com/articles/s41591-021-01594-1

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the si...

Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide https://www.nature.com/art...
12/28/2021

Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide https://www.nature.com/articles/s41591-021-01557-6

An antisense oligonucleotide targets mutant transcripts of the ALS gene C9orf72, suppressing the poly(GP) dipeptide in tissues in mice and in the spinal fluid of a single patient harboring the C9orf72 gene mutation

Address

Safety Harbor, FL
34695

Alerts

Be the first to know and let us send you an email when Me2Myself posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram